{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "23", "@timestamp": "2021-02-23T16:27:55.000055-05:00", "@year": "2021", "@month": "02"}, "ait:date-sort": {"@day": "02", "@year": "2013", "@month": "12"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"city-group": "Phitsanulok 65000", "country": "Thailand", "@afid": "105594869", "@country": "tha", "organization": [{"$": "Center of Pharmaceutical Outcomes Research"}, {"$": "Department of Pharmacy Practice"}, {"$": "Faculty of Pharmaceutical Sciences"}], "affiliation-id": {"@afid": "105594869", "@dptid": "110153722"}, "@dptid": "110153722"}, "author": [{"ce:given-name": "Piyemeth", "preferred-name": {"ce:given-name": "Piyemeth", "ce:initials": "P.", "ce:surname": "Dilokthornsakul", "ce:indexed-name": "Dilokthornsakul P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Dilokthornsakul", "@auid": "46061811100", "ce:indexed-name": "Dilokthornsakul P."}, {"ce:given-name": "Nathorn", "preferred-name": {"ce:given-name": "Nathorn", "ce:initials": "N.", "ce:surname": "Chaiyakunapruk", "ce:indexed-name": "Chaiyakunapruk N."}, "@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Chaiyakunapruk", "@auid": "14015058100", "ce:indexed-name": "Chaiyakunapruk N."}, {"ce:given-name": "Surasak", "preferred-name": {"ce:given-name": "Surasak", "ce:initials": "S.", "ce:surname": "Saokaew", "ce:indexed-name": "Saokaew S."}, "@seq": "5", "ce:initials": "S.", "@date-locked": "2019-06-26T16:07:13.330", "@_fa": "true", "ce:surname": "Saokaew", "@auid": "34969613100", "ce:indexed-name": "Saokaew S."}, {"ce:given-name": "Rosarin", "preferred-name": {"ce:given-name": "Rosarin", "ce:initials": "R.", "ce:surname": "Sruamsiri", "ce:indexed-name": "Sruamsiri R."}, "@seq": "6", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Sruamsiri", "@auid": "54901770300", "ce:indexed-name": "Sruamsiri R."}]}, {"affiliation": {"city-group": "Brisbane", "country": "Australia", "@afid": "60031004", "@country": "aus", "organization": [{"$": "School of Population Health"}, {"$": "University of Queensland"}], "affiliation-id": {"@afid": "60031004", "@dptid": "113770429"}, "@dptid": "113770429"}, "author": [{"ce:given-name": "Nathorn", "preferred-name": {"ce:given-name": "Nathorn", "ce:initials": "N.", "ce:surname": "Chaiyakunapruk", "ce:indexed-name": "Chaiyakunapruk N."}, "@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Chaiyakunapruk", "@auid": "14015058100", "ce:indexed-name": "Chaiyakunapruk N."}]}, {"affiliation": {"city-group": "Madison, WI", "country": "United States", "@afid": "60032179", "@country": "usa", "organization": [{"$": "School of Pharmacy"}, {"$": "University of Wisconsin-Madison"}], "affiliation-id": {"@afid": "60032179", "@dptid": "113731296"}, "@dptid": "113731296"}, "author": [{"ce:given-name": "Nathorn", "preferred-name": {"ce:given-name": "Nathorn", "ce:initials": "N.", "ce:surname": "Chaiyakunapruk", "ce:indexed-name": "Chaiyakunapruk N."}, "@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Chaiyakunapruk", "@auid": "14015058100", "ce:indexed-name": "Chaiyakunapruk N."}]}, {"affiliation": {"country": "Malaysia", "@afid": "60018894", "@country": "mys", "organization": [{"$": "Discipline of Pharmacy"}, {"$": "Monash University"}], "affiliation-id": {"@afid": "60018894", "@dptid": "113723897"}, "@dptid": "113723897"}, "author": [{"ce:given-name": "Nathorn", "preferred-name": {"ce:given-name": "Nathorn", "ce:initials": "N.", "ce:surname": "Chaiyakunapruk", "ce:indexed-name": "Chaiyakunapruk N."}, "@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Chaiyakunapruk", "@auid": "14015058100", "ce:indexed-name": "Chaiyakunapruk N."}]}, {"affiliation": {"country": "Malaysia", "@afid": "60028190", "@country": "mys", "organization": [{"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425653"}, "@dptid": "104425653"}, "author": [{"ce:given-name": "Wichai", "preferred-name": {"ce:given-name": "Wichai", "ce:initials": "W.", "ce:surname": "Termrungruanglert", "ce:indexed-name": "Termrungruanglert W."}, "@seq": "3", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Termrungruanglert", "@auid": "6602997018", "ce:indexed-name": "Termrungruanglert W."}]}, {"affiliation": {"city-group": "Phitsanulok", "country": "Malaysia", "@afid": "114018248", "@country": "mys", "organization": [{"$": "Faculty of Public Health"}, {"$": "Naresuan University"}], "affiliation-id": {"@afid": "114018248", "@dptid": "114019316"}, "@dptid": "114019316"}, "author": [{"ce:given-name": "Chayanin", "preferred-name": {"ce:given-name": "Chayanin", "ce:initials": "C.", "ce:surname": "Pratoomsoot", "ce:indexed-name": "Pratoomsoot C."}, "@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Pratoomsoot", "@auid": "22956338900", "ce:indexed-name": "Pratoomsoot C."}]}, {"affiliation": {"city-group": "Phayao", "country": "Thailand", "@afid": "60114221", "@country": "tha", "organization": [{"$": "School of Pharmaceutical Sciences"}, {"$": "University of Phayao"}], "affiliation-id": {"@afid": "60114221", "@dptid": "121923933"}, "@dptid": "121923933"}, "author": [{"ce:given-name": "Surasak", "preferred-name": {"ce:given-name": "Surasak", "ce:initials": "S.", "ce:surname": "Saokaew", "ce:indexed-name": "Saokaew S."}, "@seq": "5", "ce:initials": "S.", "@date-locked": "2019-06-26T16:07:13.330", "@_fa": "true", "ce:surname": "Saokaew", "@auid": "34969613100", "ce:indexed-name": "Saokaew S."}]}, {"affiliation": {"city-group": "Chicago, IL", "country": "United States", "@afid": "60027561", "@country": "usa", "organization": [{"$": "Center for Pharmacoepidemiology and Pharmacoeconomic Research"}, {"$": "College of Pharmacy"}, {"$": "University of Illinois at Chicago"}], "affiliation-id": {"@afid": "60027561", "@dptid": "108058498"}, "@dptid": "108058498"}, "author": [{"ce:given-name": "Piyemeth", "preferred-name": {"ce:given-name": "Piyemeth", "ce:initials": "P.", "ce:surname": "Dilokthornsakul", "ce:indexed-name": "Dilokthornsakul P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Dilokthornsakul", "@auid": "46061811100", "ce:indexed-name": "Dilokthornsakul P."}]}], "citation-title": "The effects of metformin on ovarian cancer: A systematic review", "abstracts": "Objective: The potential therapeutic effects of metformin on several cancerswere reported. However, the evidence of the effects of metformin on ovarian cancer is still limited and inconclusive. This systematic review and meta-analysis study aims to summarize the existing evidence of the therapeutic effects of metformin on ovarian cancer. Methods: We performed systematic searches using electronic databases including PubMed and EMBASE until December 2012. Key words included \"metformin\" AND (\"ovarian cancer\" OR \"ovary tumor\"). All human studies assessing the effects of metformin on ovarian cancer were eligible for inclusion. All articles were reviewed independently by 2 authors with a standardized approach for the purpose of study, study design, patient characteristics, exposure, and outcomes. The data were pooled using a random-effects model. Results: Of 190 studies retrieved, only 3 observational studies and 1 report of 2 randomized controlled trials were included. Among those studies, 2 reported the effects of metformin on survival outcomes of ovarian cancer, whereas the other 2 reported the effects of metformin on ovarian cancer prevention. The findings of studies reporting the effects on survival outcomes indicated that metformin may prolong overall, disease-specific, and progression-free survival in ovarian cancer patients. The results of studies reporting the effects of metformin on ovarian cancer prevention were meta-analyzed. It indicated that metformin tended to decrease occurrence of ovarian cancer among diabetic patients with the pooled odds ratio of 0.57 (95% confidence interval, 0.16-1.99). Conclusions: Our findings showed the potential therapeutic effects of metformin on survival outcomes of ovarian cancer and ovarian cancer prevention. However, most of the evidence was observational studies. There is a call for further well-conducted controlled clinical trials to confirm the effects of metformin on ovarian cancer survival and ovarian cancer prevention. Copyright \u00a9 2013 by IGCS and ESGO.", "correspondence": {"affiliation": {"city-group": "Phitsanulok 65000", "country": "Thailand", "@country": "tha", "organization": [{"$": "Center of Pharmaceutical Outcomes Research"}, {"$": "Department of Pharmacy Practice"}, {"$": "Faculty of Pharmaceutical Sciences"}]}, "person": {"ce:initials": "P.", "ce:surname": "Dilokthornsakul", "ce:indexed-name": "Dilokthornsakul P."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Diabetes mellitus", "@xml:lang": "eng"}, {"$": "Meta-analysis", "@xml:lang": "eng"}, {"$": "Metformin", "@xml:lang": "eng"}, {"$": "Ovarian cancer", "@xml:lang": "eng"}, {"$": "Systematic review", "@xml:lang": "eng"}]}, "citation-type": {"@code": "re"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"codencode": "IJGCE", "sourcetitle-abbrev": "Int. J. Gynecol. Cancer", "@country": "usa", "issn": [{"$": "1048891X", "@type": "print"}, {"$": "15251438", "@type": "electronic"}], "volisspag": {"voliss": {"@volume": "23", "@issue": "9"}, "pagerange": {"@first": "1544", "@last": "1551"}}, "@type": "j", "publicationyear": {"@first": "2013"}, "sourcetitle": "International Journal of Gynecological Cancer", "@srcid": "27518", "publicationdate": {"year": "2013", "date-text": {"@xfab-added": "true", "$": "2013"}}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": [{"classification-code": "87.1.4", "classification-description": "CANCER RESEARCH; EPIDEMIOLOGY AND AETIOLOGY; Chemoprevention of Cancer"}, {"classification-code": "87.5.14", "classification-description": "CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Ovary"}, {"classification-code": "87.7.1", "classification-description": "CANCER RESEARCH; GENERAL CONCEPTS; Reviews"}]}, {"@type": "EMCLASS", "classification": [{"classification-code": "10.3.6", "classification-description": "Obstetrics and Gynecology; GYNECOLOGY; Ovaries and fallopian tubes"}, {"classification-code": "16.17.2", "classification-description": "Cancer; REPRODUCTIVE SYSTEM; Female reproductive system"}, {"classification-code": "30.4", "classification-description": "Clinical and Experimental Pharmacology; PHARMACODYNAMICS"}, {"classification-code": "30.5.8", "classification-description": "Clinical and Experimental Pharmacology; EFFECTS ON ORGANS AND SYSTEMS; Reproductive system"}, {"classification-code": "30.6.4", "classification-description": "Clinical and Experimental Pharmacology; PHARMACOLOGICAL AGENTS; Antineoplastic agents"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}]}, {"@type": "ASJC", "classification": [{"$": "2730"}, {"$": "2729"}]}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": {"@source": "esbd", "chemical": [{"cas-registry-number": "9004-10-8", "chemical-name": "insulin"}, {"cas-registry-number": [{"$": "1115-70-4"}, {"$": "657-24-9"}], "chemical-name": "metformin"}]}}}}, "item-info": {"copyright": {"$": "Copyright 2013 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "CABS"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}, {"$": "MEDL"}], "history": {"date-created": {"@day": "02", "@year": "2013", "@month": "12"}}, "itemidlist": {"itemid": [{"$": "370352297", "@idtype": "PUI"}, {"$": "2013749670", "@idtype": "EMBASE"}, {"$": "2013364717", "@idtype": "CABS"}, {"$": "84888334337", "@idtype": "SCP"}, {"$": "84888334337", "@idtype": "SGR"}, {"$": "1370352297", "@idtype": "PUIsecondary"}, {"$": "353092130", "@idtype": "CAR-ID"}, {"$": "24172091", "@idtype": "MEDL"}], "ce:doi": "10.1097/IGC.0b013e3182a80a21"}}, "tail": {"bibliography": {"@refcount": "36", "reference": [{"ref-fulltext": "American Cancer Society. Ovarian Cancer. 2012. Available at: http://www.cancer.org/cancer/ovariancancer/detailedguide/ovarian-cancer-key- statistics. Accessed January 17, 2013.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-website": {"ce:e-address": {"$": "http://www.cancer.org/cancer/ovariancancer/detailedguide/ ovarian-cancer-key-statistics", "@type": "url"}}, "refd-itemidlist": {"itemid": {"$": "57149130267", "@idtype": "SGR"}}, "ref-text": "American Cancer Society. Accessed January 17 2013", "ref-sourcetitle": "Ovarian Cancer"}}, {"ref-fulltext": "National Cancer Institute. SEER Stat Fact Sheets: Ovary. 2012. Available at: http://seer.cancer.gov/statfacts/html/ovary.html. Accessed January 17, 2013.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-website": {"ce:e-address": {"$": "http://seer.cancer.gov/statfacts/html/ovary.html", "@type": "url"}}, "refd-itemidlist": {"itemid": {"$": "79952945610", "@idtype": "SGR"}}, "ref-text": "National Cancer Institute. Accessed January 17 2013", "ref-sourcetitle": "SEER Stat Fact Sheets: Ovary"}}, {"ref-fulltext": "American Cancer Society. Global Cancer Facts & Figures. 2nd ed. Atlanta, GA: American Cancer Society; 2011.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "refd-itemidlist": {"itemid": {"$": "79959990351", "@idtype": "SGR"}}, "ref-text": "American Cancer Society. 2nd ed. Atlanta, GA: American Cancer Society;", "ref-sourcetitle": "Global Cancer Facts & Figures"}}, {"ref-fulltext": "Roett MA, Evans P. Ovarian cancer: an overview. Am Fam Physician. 2009; 80: 609-616.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Ovarian cancer: An overview"}, "refd-itemidlist": {"itemid": {"$": "70349222742", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "80"}, "pagerange": {"@first": "609", "@last": "616"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Roett", "ce:indexed-name": "Roett M.A."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Evans", "ce:indexed-name": "Evans P."}]}, "ref-sourcetitle": "Am Fam Physician"}}, {"ref-fulltext": "Bakhru A, Buckanovich RJ, Griggs JJ. The impact of diabetes on survival in women with ovarian cancer. Gynecol Oncol. 2011; 121: 106-111.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "The impact of diabetes on survival in women with ovarian cancer"}, "refd-itemidlist": {"itemid": {"$": "79952817723", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "121"}, "pagerange": {"@first": "106", "@last": "111"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Bakhru", "ce:indexed-name": "Bakhru A."}, {"@seq": "2", "ce:initials": "R.J.", "@_fa": "true", "ce:surname": "Buckanovich", "ce:indexed-name": "Buckanovich R.J."}, {"@seq": "3", "ce:initials": "J.J.", "@_fa": "true", "ce:surname": "Griggs", "ce:indexed-name": "Griggs J.J."}]}, "ref-sourcetitle": "Gynecol Oncol"}}, {"ref-fulltext": "Weiderpass E, Ye W, Vainio H, et al. Diabetes mellitus and ovarian cancer (Sweden). Cancer Causes Control. 2002; 13: 759-764.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Diabetes mellitus and ovarian cancer (Sweden)"}, "refd-itemidlist": {"itemid": {"$": "0036800357", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "759", "@last": "764"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Weiderpass", "ce:indexed-name": "Weiderpass E."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Ye", "ce:indexed-name": "Ye W."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Vainio", "ce:indexed-name": "Vainio H."}], "et-al": null}, "ref-sourcetitle": "Cancer Causes Control"}}, {"ref-fulltext": "Ben Sahra I, Le Marchand-Brustel Y, Tanti JF, et al. Metformin in cancer therapy: a new perspective for an old antidiabetic drug? Mol Cancer Ther. 2010; 9: 1092-1099.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Metformin in cancer therapy: A new perspective for an old antidiabetic drug?"}, "refd-itemidlist": {"itemid": {"$": "77952116629", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "1092", "@last": "1099"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Ben Sahra", "ce:indexed-name": "Ben Sahra I."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Le Marchand-Brustel", "ce:indexed-name": "Le Marchand-Brustel Y."}, {"@seq": "3", "ce:initials": "J.F.", "@_fa": "true", "ce:surname": "Tanti", "ce:indexed-name": "Tanti J.F."}], "et-al": null}, "ref-sourcetitle": "Mol Cancer Ther"}}, {"ref-fulltext": "Baur DM, Klotsche J, Hamnvik OP, et al. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism. 2010; 60: 1363-1371.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort"}, "refd-itemidlist": {"itemid": {"$": "80052968453", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "60"}, "pagerange": {"@first": "1363", "@last": "1371"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Baur", "ce:indexed-name": "Baur D.M."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Klotsche", "ce:indexed-name": "Klotsche J."}, {"@seq": "3", "ce:initials": "O.P.", "@_fa": "true", "ce:surname": "Hamnvik", "ce:indexed-name": "Hamnvik O.P."}], "et-al": null}, "ref-sourcetitle": "Metabolism"}}, {"ref-fulltext": "Bowker SL, Yasui Y, Veugelers P, et al. Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia. 2010; 53: 1631-1637.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Glucose-lowering agents and cancer mortality rates in type 2 diabetes: Assessing effects of time-varying exposure"}, "refd-itemidlist": {"itemid": {"$": "77953537179", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "53"}, "pagerange": {"@first": "1631", "@last": "1637"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.L.", "@_fa": "true", "ce:surname": "Bowker", "ce:indexed-name": "Bowker S.L."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Yasui", "ce:indexed-name": "Yasui Y."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Veugelers", "ce:indexed-name": "Veugelers P."}], "et-al": null}, "ref-sourcetitle": "Diabetologia"}}, {"ref-fulltext": "Gotlieb WH, Saumet J, Beauchamp MC, et al. In vitro metformin anti-neoplastic activity in epithelial ovarian cancer. Gynecol Oncol. 2008; 110: 246-250.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "In vitro metformin anti-neoplastic activity in epithelial ovarian cancer"}, "refd-itemidlist": {"itemid": {"$": "47249088612", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "110"}, "pagerange": {"@first": "246", "@last": "250"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.H.", "@_fa": "true", "ce:surname": "Gotlieb", "ce:indexed-name": "Gotlieb W.H."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Saumet", "ce:indexed-name": "Saumet J."}, {"@seq": "3", "ce:initials": "M.C.", "@_fa": "true", "ce:surname": "Beauchamp", "ce:indexed-name": "Beauchamp M.C."}], "et-al": null}, "ref-sourcetitle": "Gynecol Oncol"}}, {"ref-fulltext": "Rattan R, Giri S, Hartmann LC, et al. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. J Cell Mol Med. 2009; 15: 166-178.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner"}, "refd-itemidlist": {"itemid": {"$": "78751692291", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "166", "@last": "178"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Rattan", "ce:indexed-name": "Rattan R."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Giri", "ce:indexed-name": "Giri S."}, {"@seq": "3", "ce:initials": "L.C.", "@_fa": "true", "ce:surname": "Hartmann", "ce:indexed-name": "Hartmann L.C."}], "et-al": null}, "ref-sourcetitle": "J Cell Mol Med"}}, {"ref-fulltext": "Berstein LM. Metformin in obesity, cancer and aging: addressing controversies. Aging (Albany NY). 2012; 4: 320-329.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Metformin in obesity, cancer and aging: Addressing controversies"}, "refd-itemidlist": {"itemid": {"$": "84864541430", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4"}, "pagerange": {"@first": "320", "@last": "329"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.M.", "@_fa": "true", "ce:surname": "Berstein", "ce:indexed-name": "Berstein L.M."}]}, "ref-sourcetitle": "Aging (Albany NY)"}}, {"ref-fulltext": "Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Accessed December 20, 2012.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-website": {"ce:e-address": {"$": "http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp", "@type": "url"}}, "refd-itemidlist": {"itemid": {"$": "13644257725", "@idtype": "SGR"}}, "ref-text": "Accessed December 20 2012", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Wells", "ce:indexed-name": "Wells G."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Shea", "ce:indexed-name": "Shea B."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "O'Connell", "ce:indexed-name": "O'Connell D."}], "et-al": null}, "ref-sourcetitle": "The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses"}}, {"ref-fulltext": "Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2: The Cochrane Collaboration. 2009. Updated September 2009. Available at www.cochrane-handbook.org.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-website": {"ce:e-address": {"$": "www.cochrane-handbook.org", "@type": "url"}}, "ref-title": {"ref-titletext": "Assessing risk of bias in included studies"}, "refd-itemidlist": {"itemid": {"$": "70049099036", "@idtype": "SGR"}}, "ref-text": "Higgins JPT, Green S, eds.. Updated September 2009", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.P.T.", "@_fa": "true", "ce:surname": "Higgins", "ce:indexed-name": "Higgins J.P.T."}, {"@seq": "2", "ce:initials": "D.G.", "@_fa": "true", "ce:surname": "Altman", "ce:indexed-name": "Altman D.G."}, {"@seq": "3", "ce:initials": "J.A.C.", "@_fa": "true", "ce:surname": "Sterne", "ce:indexed-name": "Sterne J.A.C."}]}, "ref-sourcetitle": "Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2: The Cochrane Collaboration"}}, {"ref-fulltext": "Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-188.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "1986"}, "ref-title": {"ref-titletext": "Meta-analysis in clinical trials"}, "refd-itemidlist": {"itemid": {"$": "0022992740", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "177", "@last": "188"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Der Simonian", "ce:indexed-name": "Der Simonian R."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Laird", "ce:indexed-name": "Laird N."}]}, "ref-sourcetitle": "Control Clin Trials"}}, {"ref-fulltext": "Higgins J, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539-1558.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Quantifying heterogeneity in a meta-analysis"}, "refd-itemidlist": {"itemid": {"$": "0037098199", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "21"}, "pagerange": {"@first": "1539", "@last": "1558"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Higgins", "ce:indexed-name": "Higgins J."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Thompson", "ce:indexed-name": "Thompson S."}]}, "ref-sourcetitle": "Stat Med"}}, {"ref-fulltext": "Begg C, Berlin J. Publication bias and dissemination of clinical research. J Natl Cancer Inst. 1989; 81: 107-115.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "1989"}, "ref-title": {"ref-titletext": "Publication bias and dissemination of clinical research"}, "refd-itemidlist": {"itemid": {"$": "0024578397", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "81"}, "pagerange": {"@first": "107", "@last": "115"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Begg", "ce:indexed-name": "Begg C."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Berlin", "ce:indexed-name": "Berlin J."}]}, "ref-sourcetitle": "J Natl Cancer Inst"}}, {"ref-fulltext": "Bodmer M, Becker C, Meier C, et al. Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecol Oncol. 2011; 123: 200-204.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Use of metformin and the risk of ovarian cancer: A case-control analysis"}, "refd-itemidlist": {"itemid": {"$": "80054767295", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "123"}, "pagerange": {"@first": "200", "@last": "204"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Bodmer", "ce:indexed-name": "Bodmer M."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Becker", "ce:indexed-name": "Becker C."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Meier", "ce:indexed-name": "Meier C."}], "et-al": null}, "ref-sourcetitle": "Gynecol Oncol"}}, {"ref-fulltext": "Home PD, Kahn SE, Jones NP, et al. Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials. Diabetologia. 2010; 53: 1838-1845.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical trials"}, "refd-itemidlist": {"itemid": {"$": "77955558076", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "53"}, "pagerange": {"@first": "1838", "@last": "1845"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.D.", "@_fa": "true", "ce:surname": "Home", "ce:indexed-name": "Home P.D."}, {"@seq": "2", "ce:initials": "S.E.", "@_fa": "true", "ce:surname": "Kahn", "ce:indexed-name": "Kahn S.E."}, {"@seq": "3", "ce:initials": "N.P.", "@_fa": "true", "ce:surname": "Jones", "ce:indexed-name": "Jones N.P."}], "et-al": null}, "ref-sourcetitle": "Diabetologia"}}, {"ref-fulltext": "Kumar S, Meuter A, Thapa P, et al. Metformin intake is associated with better survival in ovarian cancer: a case-control study. Cancer. 2013; 119: 555-562.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Metformin intake is associated with better survival in ovarian cancer: A case-control study"}, "refd-itemidlist": {"itemid": {"$": "84872978681", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "119"}, "pagerange": {"@first": "555", "@last": "562"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Kumar", "ce:indexed-name": "Kumar S."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Meuter", "ce:indexed-name": "Meuter A."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Thapa", "ce:indexed-name": "Thapa P."}], "et-al": null}, "ref-sourcetitle": "Cancer"}}, {"ref-fulltext": "Romero IL, McCormick A, McEwen KA, et al. Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity. Obstet Gynecol. 2012; 119: 61-67.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity"}, "refd-itemidlist": {"itemid": {"$": "84255169908", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "119"}, "pagerange": {"@first": "61", "@last": "67"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.L.", "@_fa": "true", "ce:surname": "Romero", "ce:indexed-name": "Romero I.L."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "McCormick", "ce:indexed-name": "McCormick A."}, {"@seq": "3", "ce:initials": "K.A.", "@_fa": "true", "ce:surname": "McEwen", "ce:indexed-name": "McEwen K.A."}], "et-al": null}, "ref-sourcetitle": "Obstet Gynecol"}}, {"ref-fulltext": "Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006; 355: 2427-2443.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy"}, "refd-itemidlist": {"itemid": {"$": "33845405222", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "355"}, "pagerange": {"@first": "2427", "@last": "2443"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.E.", "@_fa": "true", "ce:surname": "Kahn", "ce:indexed-name": "Kahn S.E."}, {"@seq": "2", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Haffner", "ce:indexed-name": "Haffner S.M."}, {"@seq": "3", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Heise", "ce:indexed-name": "Heise M.A."}], "et-al": null}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "Home PD, Pocock SJ, Beck-Nielsen H, et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet. 2009; 373: 2125-2135.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): A multicentre, randomised, open-label trial"}, "refd-itemidlist": {"itemid": {"$": "67149146438", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "373"}, "pagerange": {"@first": "2125", "@last": "2135"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.D.", "@_fa": "true", "ce:surname": "Home", "ce:indexed-name": "Home P.D."}, {"@seq": "2", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Pocock", "ce:indexed-name": "Pocock S.J."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Beck-Nielsen", "ce:indexed-name": "Beck-Nielsen H."}], "et-al": null}, "ref-sourcetitle": "Lancet"}}, {"ref-fulltext": "Bodmer M, Meier C, Krahenbuhl S, et al. Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care. 2010; 33: 1304-1308.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Long-term metformin use is associated with decreased risk of breast cancer"}, "refd-itemidlist": {"itemid": {"$": "77953539812", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "33"}, "pagerange": {"@first": "1304", "@last": "1308"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Bodmer", "ce:indexed-name": "Bodmer M."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Meier", "ce:indexed-name": "Meier C."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Krahenbuhl", "ce:indexed-name": "Krahenbuhl S."}], "et-al": null}, "ref-sourcetitle": "Diabetes Care"}}, {"ref-fulltext": "DeCensi A, Puntoni M, Goodwin M, et al. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis. Cancer Prev Res. 2010; 3:OF1YOF11.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Metformin and cancer risk in diabetic patients: A systematic review and meta-analysis"}, "refd-itemidlist": {"itemid": {"$": "78649302320", "@idtype": "SGR"}}, "ref-volisspag": {"pages": "OF1-OF11", "voliss": {"@volume": "3"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Decensi", "ce:indexed-name": "Decensi A."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Puntoni", "ce:indexed-name": "Puntoni M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Goodwin", "ce:indexed-name": "Goodwin M."}], "et-al": null}, "ref-sourcetitle": "Cancer Prev Res"}}, {"ref-fulltext": "Hassan MM, Curley SA, Li D, et al. Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma. Cancer. 2010; 116: 1938-1946.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Association of diabetes duration and diabetes treatment with the risk of hepatocellular carcinoma"}, "refd-itemidlist": {"itemid": {"$": "77951006620", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "116"}, "pagerange": {"@first": "1938", "@last": "1946"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Hassan", "ce:indexed-name": "Hassan M.M."}, {"@seq": "2", "ce:initials": "S.A.", "@_fa": "true", "ce:surname": "Curley", "ce:indexed-name": "Curley S.A."}, {"@seq": "3", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li D."}], "et-al": null}, "ref-sourcetitle": "Cancer"}}, {"ref-fulltext": "Landman GW, Kleefstra N, van Hateren KJ, et al. Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care. 2010; 33: 322-326.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16"}, "refd-itemidlist": {"itemid": {"$": "75149179169", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "33"}, "pagerange": {"@first": "322", "@last": "326"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "G.W.", "@_fa": "true", "ce:surname": "Landman", "ce:indexed-name": "Landman G.W."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Kleefstra", "ce:indexed-name": "Kleefstra N."}, {"@seq": "3", "ce:initials": "K.J.", "@_fa": "true", "ce:surname": "Van Hateren", "ce:indexed-name": "Van Hateren K.J."}], "et-al": null}, "ref-sourcetitle": "Diabetes Care"}}, {"ref-fulltext": "Noto H, Goto A, Tsujimoto T, et al. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS ONE. 2012; 7:e33411.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Cancer risk in diabetic patients treated with metformin: A systematic review and meta-analysis"}, "refd-itemidlist": {"itemid": {"$": "84858695046", "@idtype": "SGR"}}, "ref-volisspag": {"pages": "e33411", "voliss": {"@volume": "7"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Noto", "ce:indexed-name": "Noto H."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Goto", "ce:indexed-name": "Goto A."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Tsujimoto", "ce:indexed-name": "Tsujimoto T."}], "et-al": null}, "ref-sourcetitle": "PLoS ONE"}}, {"ref-fulltext": "Lee MS, Hsu CC,Wahlqvist ML, et al. Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals. BMC Cancer. 2011; 11:20.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: A representative population prospective cohort study of 800,000 individuals"}, "refd-itemidlist": {"itemid": {"$": "78651451726", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "20"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.S.", "@_fa": "true", "ce:surname": "Lee", "ce:indexed-name": "Lee M.S."}, {"@seq": "2", "ce:initials": "C.C.", "@_fa": "true", "ce:surname": "Hsu", "ce:indexed-name": "Hsu C.C."}, {"@seq": "3", "ce:initials": "M.L.", "@_fa": "true", "ce:surname": "Wahlqvist", "ce:indexed-name": "Wahlqvist M.L."}], "et-al": null}, "ref-sourcetitle": "BMC Cancer"}}, {"ref-fulltext": "Kourelis TV, Siegel RD. Metformin and cancer: new applications for an old drug. Med Oncol. 2012; 29: 1314-1327.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Metformin and cancer: New applications for an old drug"}, "refd-itemidlist": {"itemid": {"$": "84864371674", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "1314", "@last": "1327"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.V.", "@_fa": "true", "ce:surname": "Kourelis", "ce:indexed-name": "Kourelis T.V."}, {"@seq": "2", "ce:initials": "R.D.", "@_fa": "true", "ce:surname": "Siegel", "ce:indexed-name": "Siegel R.D."}]}, "ref-sourcetitle": "Med Oncol"}}, {"ref-fulltext": "Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009; 9: 563-575.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "The LKB1-AMPK pathway: Metabolism and growth control in tumour suppression"}, "refd-itemidlist": {"itemid": {"$": "67749111502", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "563", "@last": "575"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.B.", "@_fa": "true", "ce:surname": "Shackelford", "ce:indexed-name": "Shackelford D.B."}, {"@seq": "2", "ce:initials": "R.J.", "@_fa": "true", "ce:surname": "Shaw", "ce:indexed-name": "Shaw R.J."}]}, "ref-sourcetitle": "Nat Rev Cancer"}}, {"ref-fulltext": "Yasmeen A, Beauchamp MC, Piura E, et al. Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the Bcl-2 family proteins. . Gynecol Oncol. 2011; 121: 492-498.", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins"}, "refd-itemidlist": {"itemid": {"$": "79957438835", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "121"}, "pagerange": {"@first": "492", "@last": "498"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Yasmeen", "ce:indexed-name": "Yasmeen A."}, {"@seq": "2", "ce:initials": "M.C.", "@_fa": "true", "ce:surname": "Beauchamp", "ce:indexed-name": "Beauchamp M.C."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Piura", "ce:indexed-name": "Piura E."}], "et-al": null}, "ref-sourcetitle": "Gynecol Oncol"}}, {"ref-fulltext": "Rattan R, Giri S, Hartmann LC, et al. Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner. J Cell Mol Med. 2011; 15: 166-178.", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Metformin attenuates ovarian cancer cell growth in an AMP-kinase dispensable manner"}, "refd-itemidlist": {"itemid": {"$": "78751692291", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "166", "@last": "178"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Rattan", "ce:indexed-name": "Rattan R."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Giri", "ce:indexed-name": "Giri S."}, {"@seq": "3", "ce:initials": "L.C.", "@_fa": "true", "ce:surname": "Hartmann", "ce:indexed-name": "Hartmann L.C."}], "et-al": null}, "ref-sourcetitle": "J Cell Mol Med"}}, {"ref-fulltext": "Shank JJ, Yang K, Ghannam J, et al. Metformin targets ovarian cancer stem cells in vitro and in vivo. Gynecol Oncol. 2012; 127: 390-397.", "@id": "34", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Metformin targets ovarian cancer stem cells in vitro and in vivo"}, "refd-itemidlist": {"itemid": {"$": "84867405520", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "127"}, "pagerange": {"@first": "390", "@last": "397"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.J.", "@_fa": "true", "ce:surname": "Shank", "ce:indexed-name": "Shank J.J."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Yang", "ce:indexed-name": "Yang K."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ghannam", "ce:indexed-name": "Ghannam J."}], "et-al": null}, "ref-sourcetitle": "Gynecol Oncol"}}, {"ref-fulltext": "Morgan RJ, Alvarez RD, Armstrong DK, et al. NCCN clinical practice guideline in oncology (NCCN guideline): ovarian cancer including fallopian tube cancer and primary peritoneal cancer. 2013. Available at: http://www.nccn.org/ professionals/physician-gls/pdf/ovarian.pdf. Accessed July 2, 2013.", "@id": "35", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-website": {"ce:e-address": {"$": "http://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf", "@type": "url"}}, "refd-itemidlist": {"itemid": {"$": "84910599553", "@idtype": "SGR"}}, "ref-text": "Accessed July 2 2013", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.J.", "@_fa": "true", "ce:surname": "Morgan", "ce:indexed-name": "Morgan R.J."}, {"@seq": "2", "ce:initials": "R.D.", "@_fa": "true", "ce:surname": "Alvarez", "ce:indexed-name": "Alvarez R.D."}, {"@seq": "3", "ce:initials": "D.K.", "@_fa": "true", "ce:surname": "Armstrong", "ce:indexed-name": "Armstrong D.K."}], "et-al": null}, "ref-sourcetitle": "NCCN Clinical Practice Guideline in Oncology (NCCN Guideline): Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer"}}, {"ref-fulltext": "Erices R, Bravo ML, Gonzalez P, et al. Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells. Reprod Sci. 2013; published online May 7, 2013.", "@id": "36", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Metformin, at concentrations corresponding to the treatment of diabetes, potentiates the cytotoxic effects of carboplatin in cultures of ovarian cancer cells"}, "refd-itemidlist": {"itemid": {"$": "84887496514", "@idtype": "SGR"}}, "ref-text": "published online May 7, 2013", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Erices", "ce:indexed-name": "Erices R."}, {"@seq": "2", "ce:initials": "M.L.", "@_fa": "true", "ce:surname": "Bravo", "ce:indexed-name": "Bravo M.L."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Gonzalez", "ce:indexed-name": "Gonzalez P."}], "et-al": null}, "ref-sourcetitle": "Reprod Sci"}}]}}}}, "affiliation": [{"affiliation-city": "Phayao", "@id": "60114221", "affilname": "University of Phayao", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60114221", "affiliation-country": "Thailand"}, {"affiliation-city": "Madison", "@id": "60032179", "affilname": "University of Wisconsin-Madison", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032179", "affiliation-country": "United States"}, {"affiliation-city": "Brisbane", "@id": "60031004", "affilname": "The University of Queensland", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031004", "affiliation-country": "Australia"}, {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Chicago", "@id": "60027561", "affilname": "University of Illinois at Chicago", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027561", "affiliation-country": "United States"}, {"affiliation-city": "Bandar Sunway", "@id": "60018894", "affilname": "Monash University Malaysia", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018894", "affiliation-country": "Malaysia"}, {"affiliation-city": null, "@id": "114018248", "affilname": "Naresuan University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114018248", "affiliation-country": "Malaysia"}, {"affiliation-city": "Pitsanulok", "@id": "105594869", "affilname": "Faculty of Pharmaceutical Sciences", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/105594869", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84888334337", "dc:description": "Objective: The potential therapeutic effects of metformin on several cancerswere reported. However, the evidence of the effects of metformin on ovarian cancer is still limited and inconclusive. This systematic review and meta-analysis study aims to summarize the existing evidence of the therapeutic effects of metformin on ovarian cancer. Methods: We performed systematic searches using electronic databases including PubMed and EMBASE until December 2012. Key words included \"metformin\" AND (\"ovarian cancer\" OR \"ovary tumor\"). All human studies assessing the effects of metformin on ovarian cancer were eligible for inclusion. All articles were reviewed independently by 2 authors with a standardized approach for the purpose of study, study design, patient characteristics, exposure, and outcomes. The data were pooled using a random-effects model. Results: Of 190 studies retrieved, only 3 observational studies and 1 report of 2 randomized controlled trials were included. Among those studies, 2 reported the effects of metformin on survival outcomes of ovarian cancer, whereas the other 2 reported the effects of metformin on ovarian cancer prevention. The findings of studies reporting the effects on survival outcomes indicated that metformin may prolong overall, disease-specific, and progression-free survival in ovarian cancer patients. The results of studies reporting the effects of metformin on ovarian cancer prevention were meta-analyzed. It indicated that metformin tended to decrease occurrence of ovarian cancer among diabetic patients with the pooled odds ratio of 0.57 (95% confidence interval, 0.16-1.99). Conclusions: Our findings showed the potential therapeutic effects of metformin on survival outcomes of ovarian cancer and ovarian cancer prevention. However, most of the evidence was observational studies. There is a call for further well-conducted controlled clinical trials to confirm the effects of metformin on ovarian cancer survival and ovarian cancer prevention. Copyright \u00a9 2013 by IGCS and ESGO.", "pubmed-id": "24172091", "prism:coverDate": "2013-12-02", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84888334337", "dc:creator": {"author": [{"ce:given-name": "Piyemeth", "preferred-name": {"ce:given-name": "Piyemeth", "ce:initials": "P.", "ce:surname": "Dilokthornsakul", "ce:indexed-name": "Dilokthornsakul P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "affiliation": [{"@id": "105594869", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/105594869"}, {"@id": "60027561", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027561"}], "ce:surname": "Dilokthornsakul", "@auid": "46061811100", "author-url": "https://api.elsevier.com/content/author/author_id/46061811100", "ce:indexed-name": "Dilokthornsakul P."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84888334337"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84888334337&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84888334337&origin=inward"}], "source-id": "27518", "citedby-count": "60", "prism:volume": "23", "subtype": "re", "dc:title": "The effects of metformin on ovarian cancer: A systematic review", "openaccess": "0", "prism:issn": "1048891X 15251438", "prism:issueIdentifier": "9", "subtypeDescription": "Review", "prism:publicationName": "International Journal of Gynecological Cancer", "prism:pageRange": "1544-1551", "prism:endingPage": "1551", "openaccessFlag": "false", "prism:doi": "10.1097/IGC.0b013e3182a80a21", "prism:startingPage": "1544", "dc:identifier": "SCOPUS_ID:84888334337"}, "idxterms": null, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Diabetes mellitus"}, {"@_fa": "true", "$": "Meta-analysis"}, {"@_fa": "true", "$": "Metformin"}, {"@_fa": "true", "$": "Ovarian cancer"}, {"@_fa": "true", "$": "Systematic review"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Oncology", "@code": "2730", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Obstetrics and Gynecology", "@code": "2729", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Piyemeth", "preferred-name": {"ce:given-name": "Piyemeth", "ce:initials": "P.", "ce:surname": "Dilokthornsakul", "ce:indexed-name": "Dilokthornsakul P."}, "@seq": "1", "ce:initials": "P.", "@_fa": "true", "affiliation": [{"@id": "105594869", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/105594869"}, {"@id": "60027561", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027561"}], "ce:surname": "Dilokthornsakul", "@auid": "46061811100", "author-url": "https://api.elsevier.com/content/author/author_id/46061811100", "ce:indexed-name": "Dilokthornsakul P."}, {"ce:given-name": "Nathorn", "preferred-name": {"ce:given-name": "Nathorn", "ce:initials": "N.", "ce:surname": "Chaiyakunapruk", "ce:indexed-name": "Chaiyakunapruk N."}, "@seq": "2", "ce:initials": "N.", "@_fa": "true", "affiliation": [{"@id": "105594869", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/105594869"}, {"@id": "60031004", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031004"}, {"@id": "60032179", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60032179"}, {"@id": "60018894", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018894"}], "ce:surname": "Chaiyakunapruk", "@auid": "14015058100", "author-url": "https://api.elsevier.com/content/author/author_id/14015058100", "ce:indexed-name": "Chaiyakunapruk N."}, {"ce:given-name": "Wichai", "preferred-name": {"ce:given-name": "Wichai", "ce:initials": "W.", "ce:surname": "Termrungruanglert", "ce:indexed-name": "Termrungruanglert W."}, "@seq": "3", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Termrungruanglert", "@auid": "6602997018", "author-url": "https://api.elsevier.com/content/author/author_id/6602997018", "ce:indexed-name": "Termrungruanglert W."}, {"ce:given-name": "Chayanin", "preferred-name": {"ce:given-name": "Chayanin", "ce:initials": "C.", "ce:surname": "Pratoomsoot", "ce:indexed-name": "Pratoomsoot C."}, "@seq": "4", "ce:initials": "C.", "@_fa": "true", "affiliation": {"@id": "114018248", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/114018248"}, "ce:surname": "Pratoomsoot", "@auid": "22956338900", "author-url": "https://api.elsevier.com/content/author/author_id/22956338900", "ce:indexed-name": "Pratoomsoot C."}, {"ce:given-name": "Surasak", "preferred-name": {"ce:given-name": "Surasak", "ce:initials": "S.", "ce:surname": "Saokaew", "ce:indexed-name": "Saokaew S."}, "@seq": "5", "ce:initials": "S.", "@_fa": "true", "affiliation": [{"@id": "105594869", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/105594869"}, {"@id": "60114221", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60114221"}], "ce:surname": "Saokaew", "@auid": "34969613100", "author-url": "https://api.elsevier.com/content/author/author_id/34969613100", "ce:indexed-name": "Saokaew S."}, {"ce:given-name": "Rosarin", "preferred-name": {"ce:given-name": "Rosarin", "ce:initials": "R.", "ce:surname": "Sruamsiri", "ce:indexed-name": "Sruamsiri R."}, "@seq": "6", "ce:initials": "R.", "@_fa": "true", "affiliation": {"@id": "105594869", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/105594869"}, "ce:surname": "Sruamsiri", "@auid": "54901770300", "author-url": "https://api.elsevier.com/content/author/author_id/54901770300", "ce:indexed-name": "Sruamsiri R."}]}}}